DCF — ENLOE MEDICAL CENTER
Enterprise Value: $-221.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-221.2M
Enterprise Value
$-93.1M
PV of Cash Flows
$-128.1M
PV of Terminal Value
$-206.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $859.5M | $-0.2M | -0.0% | $-36.6M | $-33.2M |
| Year 2 | $885.2M | $8.7M | 1.0% | $-28.8M | $-23.8M |
| Year 3 | $911.8M | $18.1M | 2.0% | $-20.5M | $-15.4M |
| Year 4 | $939.2M | $23.3M | 2.0% | $-16.5M | $-11.2M |
| Year 5 | $967.3M | $26.4M | 3.0% | $-15.1M | $-9.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-221.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$834.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.00519807178426502
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5